The dopamine D3 receptor, a quarter century later
P Sokoloff, B Le Foll - European Journal of Neuroscience, 2017 - Wiley Online Library
This review updates the existing knowledge suggesting a role for the D3 receptor in
schizophrenia and drug addiction. The D3 receptor is expressed in brain regions controlling …
schizophrenia and drug addiction. The D3 receptor is expressed in brain regions controlling …
Drug addiction: a curable mental disorder?
Drug addiction is a chronic, relapsing brain disorder. Multiple neural networks in the brain
including the reward system (eg, the mesocorticolimbic system), the anti-reward/stress …
including the reward system (eg, the mesocorticolimbic system), the anti-reward/stress …
Pharmacotherapeutic agents in the treatment of methamphetamine dependence
KC Morley, JL Cornish, A Faingold… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Methamphetamine use is a serious public health concern in many countries
and is second to cannabis as the most widely abused illicit drug in the world. Effective …
and is second to cannabis as the most widely abused illicit drug in the world. Effective …
Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid …
The recent and precipitous increase in opioid analgesic abuse and overdose has inspired
investigation of the dopamine D3 receptor (D3R) as a target for therapeutic intervention …
investigation of the dopamine D3 receptor (D3R) as a target for therapeutic intervention …
Dopamine D1 and D3 receptor polypharmacology as a potential treatment approach for substance use disorder
E Galaj, S Ewing, R Ranaldi - Neuroscience & Biobehavioral Reviews, 2018 - Elsevier
In the search for efficacious pharmacotherapies to treat cocaine addiction much attention
has been given to agents targeting dopamine D1 or D3 receptors because of the …
has been given to agents targeting dopamine D1 or D3 receptors because of the …
Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats
G Yang, L Liu, R Zhang, J Li, CK Leung… - Toxicology …, 2020 - academic.oup.com
Methamphetamine (METH) is a highly addictive psychostimulant. Cannabidiol (CBD) is an
exogenous cannabinoid without psychostimulating activity, which has potential therapeutic …
exogenous cannabinoid without psychostimulating activity, which has potential therapeutic …
Cannabidiol modulates the METH-induced conditioned place preference through D2-like dopamine receptors in the hippocampal CA1 region
The main problem with addiction is a relapse with a high rate in methamphetamine (METH)
abusers. Using addictive drugs repetitively will cause the reward. METH reward is due to an …
abusers. Using addictive drugs repetitively will cause the reward. METH reward is due to an …
Naltrexone attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice
Z Wang, L Guo, X Han, R Song, G Dong, C Ma… - Behavioural brain …, 2021 - Elsevier
Methamphetamine addiction causes serious public health problems worldwide. However,
there is no effective medication licensed for methamphetamine addiction. The endogenous …
there is no effective medication licensed for methamphetamine addiction. The endogenous …
Role of dopamine D3 receptor in alleviating behavioural deficits in animal models of post-traumatic stress disorder
D Song, Y Ge, Z Chen, C Shang, Y Guo, T Zhao… - Progress in Neuro …, 2018 - Elsevier
Post-traumatic stress disorder (PTSD) is a complicated psychiatric disorder, which occurs
after exposure to a traumatic event. The main clinical manifestation of PTSD includes fear …
after exposure to a traumatic event. The main clinical manifestation of PTSD includes fear …
Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice
Y Lv, R Hu, M Jing, T Zhao, N Wu, R Song… - Acta Pharmacologica …, 2019 - nature.com
Increasing preclinical evidence demonstrates that dopamine D3 receptor (D3R) antagonists
are a potential option for the treatment of drug addiction. The reinstatement of the addiction …
are a potential option for the treatment of drug addiction. The reinstatement of the addiction …